- Home
- EEFT vs ZLAB Comparison
EEFT vs ZLAB Comparison
Compare EEFT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEFT
- ZLAB
- Stock Information
- Founded
- EEFT 1994
- ZLAB 2013
- Country
- EEFT United States
- ZLAB China
- Employees
- EEFT N/A
- ZLAB N/A
- Industry
- EEFT EDP Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- EEFT Technology
- ZLAB Health Care
- Exchange
- EEFT Nasdaq
- ZLAB Nasdaq
- Market Cap
- EEFT 4.1B
- ZLAB 3.5B
- IPO Year
- EEFT 1997
- ZLAB 2017
- Fundamental
- Price
- EEFT $108.30
- ZLAB $29.24
- Analyst Decision
- EEFT Buy
- ZLAB Buy
- Analyst Count
- EEFT 7
- ZLAB 4
- Target Price
- EEFT $125.57
- ZLAB $47.37
- AVG Volume (30 Days)
- EEFT 471.6K
- ZLAB 1.2M
- Earning Date
- EEFT 04-23-2025
- ZLAB 05-08-2025
- Dividend Yield
- EEFT N/A
- ZLAB N/A
- EPS Growth
- EEFT 18.66
- ZLAB N/A
- EPS
- EEFT 6.80
- ZLAB N/A
- Revenue
- EEFT $4,048,300,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- EEFT $9.78
- ZLAB $44.43
- Revenue Next Year
- EEFT $7.63
- ZLAB $48.68
- P/E Ratio
- EEFT $15.92
- ZLAB N/A
- Revenue Growth
- EEFT 7.73
- ZLAB 43.72
- 52 Week Low
- EEFT $85.24
- ZLAB $15.65
- 52 Week High
- EEFT $117.66
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- EEFT 64.35
- ZLAB 42.71
- Support Level
- EEFT $97.45
- ZLAB $27.61
- Resistance Level
- EEFT $108.82
- ZLAB $32.02
- Average True Range (ATR)
- EEFT 3.24
- ZLAB 1.23
- MACD
- EEFT 1.42
- ZLAB -0.18
- Stochastic Oscillator
- EEFT 97.00
- ZLAB 23.41
About EEFT Euronet Worldwide Inc.
Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.